Time Course of Morphologic Effects on Different Retinal Compartments after Ranibizumab Therapy in Age-related Macular Degeneration
Authors:
- Isabelle GolbazIGIsabelle Golbaz
- Geraldine StockGSGeraldine Stock
- Alexander FousAFAlexander Fous
- Sheila KolarSKSheila Kolar
- Christian PruenteCPChristian Pruente
- Ursula Schmidt-ErfurthUSUrsula Schmidt-Erfurth
- 1 August 2008
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 115 (8) , e39-e46
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Noninvasive Volumetric Imaging and Morphometry of the Rodent Retina with High-Speed, Ultrahigh-Resolution Optical Coherence TomographyInvestigative Ophthalmology & Visual Science, 2006
- Ultra-high Resolution Optical Coherence Tomography Assessment of Photoreceptors in Retinitis Pigmentosa and Related DiseasesAmerican Journal of Ophthalmology, 2006
- Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- High-Definition and 3-dimensional Imaging of Macular Pathologies with High-speed Ultrahigh-Resolution Optical Coherence TomographyOphthalmology, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Pegaptanib Sodium for Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- Prevalence of Age-Related Macular Degeneration in 4 Racial/Ethnic Groups in the Multi-ethnic Study of AtherosclerosisOphthalmology, 2006
- Errors in Retinal Thickness Measurements Obtained by Optical Coherence TomographyOphthalmology, 2006
- Ultrahigh resolution optical coherence tomography in non-exudative age related macular degenerationBritish Journal of Ophthalmology, 2006
- Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical StudyOphthalmology, 2005